March 16, 2020 / 10:36 AM / 19 days ago

BRIEF-Cytodyn Inc Files Modified IND And Protocol For Phase 2 Clinical Trial For Treatment Of Patients With Coronavirus With Leronlimab (Pro 140)

March 16 (Reuters) - Cytodyn Inc:

* CYTODYN INC - FILES MODIFIED IND AND PROTOCOL FOR PHASE 2 CLINICAL TRIAL FOR TREATMENT OF PATIENTS WITH CORONAVIRUS WITH LERONLIMAB (PRO 140) Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below